DeepMed Research

Urotronic, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

Recruiting

Conditions: Benign Prostatic Hyperplasia

Interventions: Other: Data collection

First Posted Date: 2024-08-19

Last Posted Date: 2025-03-10

Lead Sponsor: Urotronic Inc.

Target Recruit Count: 500

Registration Number: NCT06560476

Locations: 🇺🇸
Florida Urology Partners, Tampa, Florida, United States
🇺🇸
Sheldon Freedman, Ltd, Las Vegas, Nevada, United States
🇺🇸
Golden State Urology, Sacramento, California, United States

and more 5 locations

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

Not Applicable

Recruiting

Conditions: Benign Prostatic Hyperplasia

Interventions: Device: Optilume® BPH Catheter System

First Posted Date: 2024-03-15

Last Posted Date: 2024-11-07

Lead Sponsor: Urotronic Inc.

Target Recruit Count: 92

Registration Number: NCT06312722

Locations: 🇺🇸
Arkansas Urology, Little Rock, Arkansas, United States
🇺🇸
Florida Urology Partners, LLP, Tampa, Florida, United States
🇺🇸
Ochsner LSU Health Shreveport - Regional Urology, Shreveport, Louisiana, United States

and more 2 locations

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

Phase 4

Recruiting

Conditions: Urethral Stricture

Interventions: Combination Product: Optilume Urethral DCB

First Posted Date: 2022-05-20

Last Posted Date: 2025-01-28

Lead Sponsor: Urotronic Inc.

Target Recruit Count: 34

Registration Number: NCT05383274

Locations: 🇺🇸
Chesapeake, Hanover, Maryland, United States
🇺🇸
Arkansas Urology, Little Rock, Arkansas, United States
🇺🇸
Orlando Health, Orlando, Florida, United States

and more 6 locations

Optilume™ BPH Catheter System in Men With Symptomatic BPH

Not Applicable

Active, not recruiting

Conditions: Benign Prostatic Hyperplasia

Interventions: Device: Optilume Sham Device
Device: Optilume BPH Catheter System

First Posted Date: 2019-10-18

Last Posted Date: 2025-04-09

Lead Sponsor: Urotronic Inc.

Target Recruit Count: 162

Registration Number: NCT04131907

Locations: 🇺🇸
Arkansas Urology, Little Rock, Arkansas, United States
🇺🇸
Colorado Clinical Research, Golden, Colorado, United States
🇺🇸
Advanced Urology Institute, Daytona Beach, Florida, United States

and more 17 locations

Re-Establishing Flow Via Drug Coated Balloon for the Treatment of Urethral Stricture Disease - Registry Study

Not Applicable

Withdrawn

Conditions: Anterior Urethral Stricture
Urethral Stricture, Anterior
Urethral Stricture
Lower Urinary Tract Symptoms

Interventions: Device: Optilume Drug Coated Balloon

First Posted Date: 2019-02-22

Last Posted Date: 2019-07-12

Lead Sponsor: Urotronic Inc.

Registration Number: NCT03851952

ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease

Not Applicable

Active, not recruiting

Conditions: Urethral Stricture

Interventions: Device: Optilume Drug Coated Balloon (DCB)
Device: Control Treatment

First Posted Date: 2018-04-17

Last Posted Date: 2024-07-01

Lead Sponsor: Urotronic Inc.

Target Recruit Count: 127

Registration Number: NCT03499964

Locations: 🇺🇸
University of Minnesota Department of Urology, Minneapolis, Minnesota, United States
🇺🇸
New Jersey Urology, Voorhees, New Jersey, United States
🇺🇸
Urology San Antonio, San Antonio, Texas, United States

and more 19 locations

Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter

Phase 2

Completed

Conditions: Benign Prostatic Hyperplasia
Benign Prostatic Hypertrophy

Interventions: Device: Optilume™ BPH Prostatic DCB Dilation Catheter
Drug: Paclitaxel

First Posted Date: 2018-02-06

Last Posted Date: 2024-10-14

Lead Sponsor: Urotronic Inc.

Target Recruit Count: 80

Registration Number: NCT03423979

Locations: 🇩🇴
Urolaser SRL, Santo Domingo Oeste, Santo Domingo, Dominican Republic
🇵🇦
Centro Especializado San Fernando, Ciudad de Panamá, Panama
🇩🇴
Centro Medico Dr. Canela, SRL, La Romana, Dominican Republic

and more 2 locations

Re-establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease

Not Applicable

Active, not recruiting

Conditions: Urethral Stricture

Interventions: Device: Urotronic Drug Coated Balloon (DCB)

First Posted Date: 2017-09-01

Last Posted Date: 2024-07-29

Lead Sponsor: Urotronic Inc.

Target Recruit Count: 16

Registration Number: NCT03270384

Locations: 🇺🇸
Urology of Virginia, Virginia Beach, Virginia, United States
🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸
Chesapeake Urology, Hanover, Maryland, United States

and more 2 locations

ROBUST I Pilot Study, Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease

Early Phase 1

Completed

Conditions: Stricture Urethra

Interventions: Combination Product: Urotronic Drug Coated Balloon (DCB)

First Posted Date: 2017-01-09

Last Posted Date: 2024-03-22

Lead Sponsor: Urotronic Inc.

Target Recruit Count: 53

Registration Number: NCT03014726

Locations: 🇺🇸
Libra Medical Inc, Brooklyn Park, Minnesota, United States

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy